The George Institute For Global Health
Global
United Kingdom
India
China
Australia

New MRFF funding for clinical trials will save lives

Media release: 
19/05/2017

The George Institute welcomes the Federal Government’s funding boost of $33 million to clinical research.

It was announced today the Australian Government will invest $13 million in clinical trial and registry activity, $5 million over four years for a national alliance partner to build the capacity of the Clinical Trials Networks (CTNs), $8 million in NHMRC fellowship schemes, and $7 million to help redesign state and territory clinical trial operating systems. 

Professor Vlado Perkovic, Executive Director, The George Institute Australia said:

“The George Institute welcomes the $33 million in Medical Research Future Fund (MRFF) investment in clinical trials and clinician researchers. As the foundation of evidence-based healthcare, investment in clinical trials will lead to better treatments for all Australians.  And it will bolster Australia’s strong reputation as a home for world class clinical trials and healthcare innovation.

“We also welcome the boost in investment for Fellowships for clinician researchers- these individuals are at the forefront of clinical innovation. Working with patients every day, they are well placed to identify the most important problems, and to find the best ways to keep people healthy. This new funding also provides much needed support and security for the next wave of Australian health and medical research leaders.  

“The Government’s investment in strengthening the clinical trials sector through national reforms is also highly important. We congratulate the Australian Clinical Trials Alliance on its new role as national clinical trials partner to help carry out this work.

“We congratulate the Prime Minister, Minister Hunt, the Department of Health, NHMRC and all those instrumental to these announcements.  

“The MRFF will save lives. Today’s announcement brings us one step closer to this outcome.”